Safety and Efficacy of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals: Week 96 Results of the Phase 3 BRIGHTE Study
Max Lataillade
(1)
,
Jacob P Lalezari
,
Michael Kozal
(2)
,
Judith A Aberg
,
Gilles Pialoux
(3, 4)
,
Pedro Cahn
(5)
,
Melanie Thompson
,
Jean-Michel Molina
(6)
,
Santiago Moreno
,
Beatriz Grinsztejn
(7)
,
Ricardo S Diaz
,
Antonella Castagna
(8)
,
Princy N Kumar
,
Gulam H Latiff
,
Edwin de Jesus
,
Marcia Wang
(9)
,
Shiven Chabria
(1)
,
Margaret Gartland
(9)
,
Amy Pierce
(1)
,
Peter Ackerman
(1)
,
Cyril Llamoso
(1)
1
ViiV Healthcare US
2 YSM - Yale School of Medicine [New Haven, Connecticut]
3 CHU Tenon [AP-HP]
4 iPLESP - Institut Pierre Louis d'Epidémiologie et de Santé Publique
5 Fundación Huésped [Buenos Aires]
6 AP-HP - Hopital Saint-Louis [AP-HP]
7 FIOCRUZ - Fundação Oswaldo Cruz / Oswaldo Cruz Foundation
8 IRCCS Ospedale San Raffaele [Milan, Italy]
9 GSK - GlaxoSmithKline [Research Triangle Park]
2 YSM - Yale School of Medicine [New Haven, Connecticut]
3 CHU Tenon [AP-HP]
4 iPLESP - Institut Pierre Louis d'Epidémiologie et de Santé Publique
5 Fundación Huésped [Buenos Aires]
6 AP-HP - Hopital Saint-Louis [AP-HP]
7 FIOCRUZ - Fundação Oswaldo Cruz / Oswaldo Cruz Foundation
8 IRCCS Ospedale San Raffaele [Milan, Italy]
9 GSK - GlaxoSmithKline [Research Triangle Park]
Jacob P Lalezari
- Function : Author
Judith A Aberg
- Function : Author
Melanie Thompson
- Function : Author
Santiago Moreno
- Function : Author
Ricardo S Diaz
- Function : Author
Princy N Kumar
- Function : Author
Gulam H Latiff
- Function : Author
Edwin de Jesus
- Function : Author